Cholesterol embolization syndrom Reply

Basit Öğe Kaydı
dc.authorid0000-0002-2620-9991
dc.contributor.authorDizman, Nazli
dc.contributor.authorBahat, Kubra Aydin
dc.contributor.authorÖzkanlı, Şeyma
dc.contributor.authorÖzkök, Abdullah
dc.date.accessioned2025-05-10T19:28:36Z
dc.date.issued2016
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description.abstract[No abstract available]
dc.identifier.endpage538
dc.identifier.issn1016-5169
dc.identifier.issue6
dc.identifier.pmid27665347
dc.identifier.scopusqualityQ3
dc.identifier.startpage538
dc.identifier.urihttps://hdl.handle.net/20.500.14730/7399
dc.identifier.volume44
dc.identifier.wosWOS:000392631500022
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherTurkish Soc Cardiology
dc.relation.ispartofTurk Kardiyoloji Dernegi Arsivi-Archives of The Turkish Society of Cardiology
dc.relation.publicationcategoryDiğer
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20250302
dc.subjectCyclophosphamide
dc.titleCholesterol embolization syndrom Reply
dc.typeLetter

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu